CE: Entresto: An Overview for Pharmacists
Entresto is a new drug that was developed for NYHA stage II heart failure. It was evaluated through the PARAMOUNT-HF and PARADIGM trials and showed some benefits to patients suffering from heart failure. There are many products that are approved for the treatment of heart failure to either decrease morbidity/mortality or provide symptom relief. It is a serious disease state and provides pharmacists with an opportunity to make appropriate recommendations in order to benefit patients. This review will discuss different characteristics of Entresto and some of the evidence associated with its use.